📈 Dividend / Entitlement · SGPL S.G. Power Limited, now known as Crestwell Healthcare Limited, has announced a rights issue to raise capital for its transition into the pharmaceutical sector.
- The company plans to issue 53,499,600 new ordinary shares at a price of PKR 10 per share, which represents approximately 300% of the existing paid-up capital.
- The total amount to be raised through this rights issue is PKR 534.996M.
- The rights issue is fully underwritten, ensuring that the company will receive the targeted capital.
- Book closure date is set for August 20, 2026, with trading of unpaid rights commencing on August 24, 2026.
- The last date for acceptance and payment of shares is September 14, 2026.
- Proceeds will be utilized for acquiring a 50% stake in a pharmaceutical company and for working capital needs.
- The rights issue is strategically designed to support the company's expansion into the healthcare sector, enhancing its financial position and operational capabilities.
About this brief: prepared automatically by BSL’s research systems from the company’s filing with the exchange. A summary for information, not investment advice — the original filing is the authoritative record.
Original filing (PDF)